Nephro Care India plans to raise Rs 35-40 crore via IPO

Published On 2024-05-27 07:15 GMT | Update On 2024-05-27 07:15 GMT

Kolkata: Nephro Care India Ltd, a Kidney care provider said it plans to raise Rs 35-40 crore through an initial public offering (IPO). The majority of the funds will be allocated to complete its multi-specialty hospital near Kolkata.

The IPO will comprise a fresh issuance of 45.84 lakh equity shares with a face value of Rs 10 each, said Founder and MD of Nephro Care India, Dr Pratim Sengupta.

“The IPO is scheduled next month on the NSE Emerge platform, and is subject to approvals from the bourse,” Sengupta said.

The promoter stake will stand at 60-65 per cent after dilution post the IPO, he said.

The 100-bed multi-speciality hospital at Madhyamgram near the metropolis will be inaugurated on July 1 on National Doctor’s Day, Sengupta told PTI here.

The Kolkata-based company’s upcoming medical facility is being set up at a cost of Rs 36 crore, including internal funding of around Rs 10 crore, he said.

Nephro Care India, founded in 2014, also plans to open three more kidney care units in eastern India in addition to its existing three such facilities in West Bengal.

The company posted a revenue of Rs 19.90 crore and net profit of Rs 3.4 crore during the first nine months of the 2023-24 fiscal, compared with a topline of Rs 17.09 crore and bottomline of Rs 1.94 crore in the corresponding period a year ago.

Article Source : with inputs

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Nephro Care India plans to raise Rs 35-40 crore via IPO

Similar News

Biocon appoints Rajesh Umakant Shanoy as Company Secretary, Compliance Officer

JnJ bags USFDA nod for bladder cancer treatment Inlexzo

Indian Pharma Market Grows 8.7% in August, Records Rs 20,984 Crore Sales: PharmaTrac

NPPA Clarifies Pharma Data Tender Terms, Technical Presentations on Sept 19

Active Pharm Chemicals Loses Rs 2.17 Crore in API Supply Fraud, 4 Booked

Chemist Body Seeks Transition Period, GST Input Adjustment After Tax Cut, Writes to CM

Strides Pharma Science Singapore arm, Kenox Pharma partner to develop multiple nasal spray products for US

Novartis to buy Tourmaline Bio for USD 1.4 billion